EI
eGENE, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by QIAGEN NV, was filed 19 Jun 2007.
eGENE, Inc.: what insiders have been doing
This page follows insider dealings at eGENE, Inc. as filed with SEC (Form 4). No insider at eGENE, Inc. has published a filing in the past twelve months. The most recent one dates from 19 June 2007.
Our records for eGENE, Inc. go back to 2007, with 7 purchases and no sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€128,870
7 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 19 June 2007
Declarations10 total
- 10,000 shares@ US$1.35Common StockSEC:0001181431-07-040899:0Canonical exit: 13 Sept 2007 (T+90)
- 10,000 shares@ US$1.29Common StockSEC:0001181431-07-039979:0Canonical exit: 10 Sept 2007 (T+90)
- 50,000 shares@ US$1.31Common StockSEC:0001181431-07-038061:0Canonical exit: 2 Sept 2007 (T+90)
- 5,000 shares@ US$1.31Common StockSEC:0001181431-07-037182:0Canonical exit: 29 Aug 2007 (T+90)
- 10,000 shares@ US$1.31Common StockSEC:0001181431-07-036409:0Canonical exit: 27 Aug 2007 (T+90)
- 30,000 shares@ US$1.31Common StockSEC:0001181431-07-036409:1Canonical exit: 28 Aug 2007 (T+90)
- 17,500 shares@ US$1.29Common StockSEC:0001181431-07-035406:0Canonical exit: 21 Aug 2007 (T+90)
- 240,000 shares@ US$0.45Common StockSEC:0001181431-07-030800:0
- 340,000 shares@ US$0.45Common StockSEC:0001181431-07-029362:0
- 450,000 sharesCommon StockSEC:0001010412-07-000058:0
10 of 10 declarations
About eGENE, Inc.
eGENE, Inc. is a company listed on the XNAS market, specializing in the development of genetic diagnostic solutions. It focuses on innovation in the health and biotechnology sectors.
